Scientific articles

From telogen effluvium to alopecia areata

Prof. Andrea Marliani

Index

In subjects under stress, diffuse hair thinning is often visible in thepost-frontal area almost all the way to the top. This is a fact, known to everyone actively involved in hair, but how this happens is not clear to anyone. Marino Salin spoke of “nervous incidence.” Daniele Campo speaks of “psychogenic alopecia.” Besides the classical one (activation of the hypothalamic-pituitary-cortical adrenal axis), there is an alternative, peripheral, cutaneous pathway in the stress response. This goes through a chain of neuropeptides, neurotransmitters and hormones that, released from the cutaneous nerve plexuses, have a direct effect on the skin: Nerve Growth Factor, Substance P and Catecholamines are the key mediators of the inhibitory effects on stress-induced hair growth.

Let’s see: the hair follicle possesses a rich nerve plexus. It is important and interesting to know that this follicular nerve plexus is in direct connection with the postcentral gyrus of the cerebral cortex. The follicular nerve plexus is partly composed of motor fibers but mainly of sensory fibers and by postganglionic fibers, sympathetic, amyelin, and noradrenergic free-terminating fibers.

The sensory plexus, under stimulation of Nerve Growth Factor, which increases under stress, is able to release Substance P. Substance P is believed to be the main mediator of pain signals from the periphery to nerve centers. Substance P activates mediators of inflammation, causes degranulation of macrophages and mast cells with production of lymphocyte inflammatory cytokines leading to induction of apoptosis and inhibition of proliferation of Keratinocytes in the hair follicle and on video-dermatoscope suggestive pictures appear, such as an erythematous, sunken halo surrounding the hair infundibules. We talk about neurogenic inflammation.

The sympathetic plexus, under stress, is able to release norepinephrine into the perifollicular intercellular spaces, and norepinephrine is a potent vasoconstrictor and powerful inhibitor of adenylyl cyclase which, when inhibited or blocked, inhibits or cascades the entire kinase system and with it glycolysis, the hexosomonophosphates and the Kebs cycle. Blocked glycolysis is blocked energy metabolism and with it mitosis of the hair matrix. The visible effect of noradrenaline release, which is known to all, is horripilation. But if there is excess adrenergic tone (i.e., norepinephrine) in the follicle system there is also vasoconstriction, ischemia, hypoxia, and under hypoxic conditions glycolysis leads to lactic acid formation.

Lactic acid is normally present in sweat and has, with glutamic acid and aspartic acid, a buffering function. Lactic acid formation, in the epidermis, which is equipped with the specific enzymes of glycolysis and the Krebs cycle, occurs from glucose and triglycerides. When lactic acid formation is supraphysiological, the pH of the system is lowered, the Kebs cycle (which has an ideal pH of 7.35) becomes slow and unable to dispose of pyruvic acid; thus lactic acid, similar to what occurs in a hypoxic and fatigued muscle, accumulates.

What influence does pH have in the development of these diseases?

Changes in pH are followed by changes in surface fatty acid composition. If there is excess adrenergic tone with the blockade of adenylyl cyclase there is, as mentioned above, no activation of protein kinase and thus of hormone-sensitive lipase that allows normal metabolism of triglycerides to fatty acids, and triglyceride metabolism, normally directed toward fatty acid formation, is diverted to acetyl-coenzyme A. Acetyl-coenzyme A cannot be disposed of in the Kebs cycle, because it is slowed by the acidity of the system, and takes the metabolic route of squalene, which accumulates, and further lactic acid formation, so the “short circuit” is self-maintaining.

Lo Squalene (so named because it was first isolated from shark liver) is an aliphatic acyclic hydrocarbon that, as mentioned above, is formed from lactic acid and/or triglycerides. Cholesterol is normally formed from squalene, and in the epidermis lipid biosynthesis is very active, so much so that only the epidermis can convert C14 acetate into cholesterol using precisely squalene as a precursor.

What happens with the degradation of hair sheaths?

A degradation of the hair sheaths is consistently observed in Alopecia Areata. This harm has in the past been attributed by non-medical Trichologists as Marcel Contier e Marino Salin to two “metabolic waste“: precisely lactic acid and squalene. Under these conditions, under a microscope in polarized light, in a high number of hairs extracted for trichogram we can see some, apparently strange, images. There is damage to the anchoring system of the inner sheath. According to Marino Salin, it is lactic acid that causes caustic damage to the inner sheath, which appears to be lifted from the hair cuticle. Under a polarized light microscope, what Contier and Salin believed to be lactic acid damage appears as a black spiral, a helical shape, between the hair cuticle and the inner epithelial sheath, which appears to be damaged by the “caustic” effect. The inner epithelial sheath appears to detach from the cuticle and “bag” while the outer epithelial sheath remains intact. Lactic acid (C3 H6 O3) would then lead to degradation of the inner sheath by caustic effect and hair loss, such as Telogen Effluvium, would be the consequence. Squalene, on the other hand, would appear to reach the hair shaft from the sebaceous gland and under a microscope in polarized light would appear as a dark spot that destroys the inner sheath from the outside. This phenomenon is attributable to the strong hygroscopicity of squalene, which damages the inner sheath by dehydration. In the expansion zone of Alopecia areata, damage to the inner epithelial sheath of all hairs is constantly found, and sheath damage appears to be the earliest sign of Alopecia Areata. We hypothesize that the initial damage of Alopecia Areata may be at the level of the inner epithelial sheath. This hypothesis allows us to understand how an Alopecia Areata can develop within a few hours, a fact that cannot be reconciled, in our opinion, with a strict autoimmune pathogenesis. The hair (and hairs) affected by the disease, after destruction of the sheath anchoring system, fall either in anagen than in catagen; that is, it appears that the hair attempts, unsuccessfully, to “escape into telogen,” a stage at which the pathogenic noxa at the origin of the disease can no longer strike. That portion of hair that falls into anagen appears to have suffered such extensive sheath damage that the follicle cannot even attempt to escape, through catagen, to telogen. This is in agreement with histological observations showing a marked increase in the proportion of catagen hair at the expanding edge of an Alopecia Areata. Autoimmunity would come into play only in the chronification of the disease. If this does not occur we have a Telogen Effluvium.

For more information...
Share the article on your socials!
Facebook
LinkedIn
Telegram
X

Bibliography

  1. Baadsgaard O.: “Alopecia areata: an immunologic disease? Research workshop: alopecia areata” J Invest Dermatol 1991; 96: 88 -89s.
  2. Bystryn J-C., Tamesis J. “Immunologic aspects of hair loss. Research workshop: alopecia areata” J Invest Dermatol 1991; 96: 88 – 89s.
  3. d’Ovidio R, Marliani A. et Al: “Alopecia Areata” publisher Tricoitalia 2015.
  4. Fanti P.A., Tosti A., Bardazzi F., et al “Alopecia areata: A pathological study of nonresponder patients” Skin Res 1994; 36: 60 – 68.
  5. Korandova H.: “PUVA treatment of alopecia areata” Cesko Slov Dermatol 1994; 69/3: 144 – 147.
  6. Lucarini G., Offidani A.M., Cellini A., et al “Abnormal immuno-morphological features of hair follicles in alopecia areata” Eur J Dermatol 1994; 4: 232 – 237.
  7. Madani S., Shapiro J.: “Alopecia areata update” J Am Acad Dermatol 2000; 42: 459 – 466.
  8. McDonagh A.J.G., Messenger A.G.: “The aetiology and pathogenesis of alopecia areata” J Dermatol Sci 1994; 7/suppl: s125 – s135.
  9. Messenger A.G., Bleehen S.S.: “Alopecia areata: light and electron microscopic pathology of the regrowing white hair” Br J Dermatol 1984; 110: 155 – 162.
  10. Messenger A.G., Slader D.N., Bleehen S.S.: “Alopecia areata, alterations in the hair growth cycle and correlation with the follicular pathology” Br J Dermatol 1986; 144: 337 – 347.
  11. Micali G, Licastro Cicero R, Nasca MR, Sapuppo A: “Treatment of alopecia areata with squaric acid dibutylester” Int J Dermatol 1996; 35: 52 – 56.

1.2 Michie H.J., Jahoda C.A.B., Oliver R.F., Johnson B.E.: “The DEBR rat : an animal model of human alopecia areata” Br J Dermatol 1991; 125: 94 – 100.

  1. Misciali C., Ciattaglia G., Tosto A., Varotti C.: ” Alopecia areata” Eur J Dermatol 1994; 4: 405 – 406.
  2. MitcheIl A.I., Krull E.A.: “Alopecia areata: pathogenesis and treatment” J Am Acad Dermatol 1984; 11: 763 – 75.
  3. Nelson B.R., Ratner D., Weiner N.D., et al: “Efficacy of topical cyclosporin A in the treatment of alopecia areata” J Dermatol Treat 1994; 5: 77 – 79.
  4. Nickoloff B.J., Griffiths C.E.M.: “Aberrant intercellular adhesion molecule-1 (ICAM-1) expression by hair- follicle epithelial cells and endothelial leukocyte adhesion molecule (ELAM-1) by vascular cells are important adhesion-molecule alterations in alopecia areata. Reaserch workshop: alopecia areata” J Invest Dermatol 1991; 96: 91 – 92s.
  5. Olsen E., Hordinsky M., McDonald-Hull S., et al: “Alopecia areata investigational assessment guidelines” J Am Acad Dermatol 1999; 40:242-246.
  6. Ogawa H., Imai R., Nishiyama S., et al: “The effect of an anti-allergic drug on the disease activity of alopecia areata” Skin Res 1994; 36: 60 – 68.
  7. Orecchia G., Cuccia Belvedere M., Martinetti M., Cappelli E., Rabbiosi G.: “Human leukocyte antigen region involvement in the genetic predisposition to alopecia areata” Dermatologica 1987; 175: 10 – 14.
  8. Orkin M., Frichot B.C., Zelickson A.S.: “Cerebriform intradermal nevus. a cause of cutis verticis gyrata” Arch Dermatol 1974; 110: 575.
  9. Price V.: “Alopecia areata: clinical aspects” J Invest Dermatol 199; 96: 68s.
  10. Rebora A.: “Alopecia areata incognita: a hypotesis” Dermatologica 1987; 174: 214.
  11. Sawaya M. E., Bakshandeh H., Hordinsky M. K., Penneys N. S.: “CD44 expression in alopecia areata and androgenetic alopecia” J Cutaneus Pathol 1994; 21: 229 – 232.
  12. Tobin D.J., Orentreich N., Fendon D.A., et al: ” Antibodies to hair follicles in alopecia areata” J Invest Dermatol 1994; 102: 721 – 724.

2.5 Whiting D.A.: “The treatment of alopecia areata” Cutis 1987,40: 247 – 50.

  1. Zhang J.G., Oliver R.F.: “Immunohistological study of the development of the cellular infiltrate in the pelage follicles of the DEBR model for alopecia areata” Br J Dermatol 1994; 130: 405 – 414.
  2. Bettucciu I.: “Extraction and characterization of hair functional substances” Thesis University of Camerino. Master of Science in Pharmacy degree program 2019.
  3. Perinelli Romano Diego et Al: “Analytical determination of squalene content in the hair follicle,” GITri 46, p. 36; 2020
  4. Perinelli Romano Diego et Al: “Preliminary evidence related to the analysis performed on the determination of lactic acid in the hair follicle” GITri 47, p. 25; 2021In this report we present the clinical case of a patient, 48 years old, Italian nationality, suffering from grade 2a (according to Ludwig’s scale) androgenetic alopecia.

Do you need information?

write to us, we are here for you

We will get back to you as soon as possible.
Whether you are a customer or want to work with us, you are always our priority.